Genetic Technologies

(NASDAQ:GENE)

$1.5691

0.0091[0.58%]

At close: Aug 24

$1.50

-0.0691[-4.40%]

After Hours: 8:28AM EDT

Day High/Low1.5 - 1.63

52 Week High/Low0.95 - 2.12

Open / Close1.63 / 1.57

Float / Outstanding- / 15.4M

Vol / Avg.17.8K / 75.3K

Mkt Cap24.1M

P/E-

50d Avg. Price1.42

Div / Yield-

Payout Ratio-

EPS0

Total Float-

Genetic Technologies (NASDAQ:GENE), Quotes and News Summary

Q: What sector and industry does Genetic Technologies (GENE) operate in?

Genetic Technologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

Genetic Technologies (NASDAQ: GENE)

Day High/Low1.5 - 1.63

52 Week High/Low0.95 - 2.12

Open / Close1.63 / 1.57

Float / Outstanding- / 15.4M

Vol / Avg.17.8K / 75.3K

Mkt Cap24.1M

P/E-

50d Avg. Price1.42

Div / Yield-

Payout Ratio-

EPS0

Total Float-

Sector: Health Care.Industry: Life Sciences Tools & Services

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States.

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Genetic Technologies Questions & Answers

How do I buy Genetic Technologies (GENE) stock?

You can purchase shares of Genetic Technologies (NASDAQ: GENE) through any online brokerage.

View our list of the best stock brokerages.

Who are Genetic Technologies's (GENE) competitors?

Other companies in Genetic Technologies’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codex DNA (NASDAQ:DNAY), IsoPlexis (NASDAQ:ISO), Personalis (NASDAQ:PSNL) and Quoin Pharmaceuticals (NASDAQ:QNRX).

What is the target price for Genetic Technologies (GENE) stock?

The latest price target for Genetic Technologies (NASDAQ: GENE) was reported by Ladenburg Thalmann on Friday, November 16, 2012. The analyst firm set a price target for 0.00 expecting GENE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Genetic Technologies (GENE)?

The stock price for Genetic Technologies (NASDAQ: GENE) is $1.5691 last updated August 24, 2022, 7:55 PM UTC.

Does Genetic Technologies (GENE) pay a dividend?

There are no upcoming dividends for Genetic Technologies.

When is Genetic Technologies (NASDAQ:GENE) reporting earnings?

Genetic Technologies does not have any upcoming earnings scheduled.

Is Genetic Technologies (GENE) going to split?

There is no upcoming split for Genetic Technologies.

What sector and industry does Genetic Technologies (GENE) operate in?

Genetic Technologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD

BTC/USD

Genetic Technologies (NASDAQ:GENE), Quotes and News Summary

Analyst Ratings

Genetic Technologies Questions & Answers